EmtA, a rRNA methyltransferase conferring high-level evernimicin resistance

Molecular Microbiology

Volumn 41, Issue 6, 2001, Pages 1349-1356

  Mann, Paul A ^a   Xiong, Liqun ^b   Mankin, Alexander S ^b   Chau, Andrew S ^a   Mendrick, Cara A ^a   Najarian, David J ^a   Cramer, Christina A ^a   Loebenberg, David ^a   Coates, Elizabeth ^a   Murgolo, Nicholas J ^a   Aarestrup, Frank M ^c   Goering, Richard V ^d   Black, Todd A ^a   Hare, Roberta S ^a   McNicholas, Paul M ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^d CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EVERNIMICIN; METHYLTRANSFERASE; PROTEIN SUBUNIT; RIBOSOME RNA;

ANTIBIOTIC RESISTANCE; ARTICLE; ASSAY; CONTROLLED STUDY; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; GENE LOCATION; GENETIC PROCEDURES; METHYLATION; NONHUMAN; PLASMID; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; RIBOSOME; RNA ANALYSIS; RNA TRANSLATION; SEQUENCE ANALYSIS;

AMINOGLYCOSIDES; ANIMALS; ANTI-BACTERIAL AGENTS; BASE SEQUENCE; BINDING SITES; CLONING, MOLECULAR; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECIUM; GENES, BACTERIAL; HUMANS; METHYLTRANSFERASES; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; PLASMIDS; RIBOSOMES; RNA, BACTERIAL; RNA, RIBOSOMAL;

ANIMALIA; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; POSIBACTERIA;

EID: 0034786898     PISSN: 0950382X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2958.2001.02602.x     Document Type: Article

References (37)

1. Association between decreased susceptibility to a new antibiotic for treatment of human diseases, evernimicin, and resistance to an antibiotic used for growth promotion in animals, avilamycin
2. Presence of variations in ribosomal protein L16 corresponding to susceptibility of enterococci to oligosaccharides
3. Surveillance of antimicrobial resistance in bacteria isolated from food animals to antimicrobial growth promoters and related therapeutic agents in Denmark
4. Resistance to antimicrobial agents used for animal therapy in pathogenic-, zoonotic- and indicator-bacteria isolated from different food animals in Denmark: A baseline study for the Danish Integrated Antimicrobial Resistance Monitoring Program (DANMAP)
5. Mutations in ribosomal protein L16 conferring reduced susceptibility to evernimicin (SCH 27899): Implications for mechanism of action
6. Evernimicin (SCH27899) inhibits a novel ribosome target site: An analysis of 23S rDNA mutants
7. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs
8. A novel antibiotic binding site in the ribosome: Interaction of evernimicin with the large ribosomal subunit
9. Activation and inactivation of Pseudomonas stutzeri methylbenzene catabolism pathways mediated by a transposable element
10. Gene organization of the Streptococcus pyrogenes plasmid pDB101: Sequence analysis of the orfη-copS region
11. Bacterial ribosome subunit synthesis: A novel antibiotic target
12. Evernimicin (SCH27899) inhibits both translation and 50S ribosomal subunit formation in Staphylococcus aureus cells
13. Protein folds from pair interactions: A blind test in fold recognition
14. The structure of new oligosaccharide antiobiotics, 13-384 components 1 and 5
15. 14C]evernimicin by fermentation and evaluation of in vivo label stability
16. Multiple-drug resistant enterococci: The nature of the problem and an agenda for the future
17. Antimicrobial activity of evernimicin, oligosaccharide member of the everninomicin class with a wide gram-positive spectrum
18. Transfer of erythromycin resistance from poultry to human clinical strains of Staphylococcus aureus
19. Sequence determination and comparison of the exfoliative toxin A and toxin B genes from Staphylococcus aureus
20. Elimination of plasmids from several bacterial species by novobiocin
21. Evernimicin binds exclusively to the 50S ribosomal subunit and inhibits translation in cell free systems derived from both gram positive and gram negative bacteria
22. Effects of mutations in ribosomal protein, L16 on susceptibility and accumulation of evernimicin
23. Insertion sequences
24. An in vitro coupled transcription-translation system from Staphylococcus aureus
25. Footprinting and modification-interference analysis of binding sites on RNA
26. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus
27. Insights into protein biosynthesis and ribosome function through inhibitors
28. IMPALA: Matching a protein sequence against a collection of PSI-BLAST constructed position-specific score matrices
29. Electroporation and efficient transformation of Enterococcus faecalis grown in high concentrations of glycine
30. Evidence for extensive resistance gene transfer among Bacteroides spp. and among Bacteroides and other genera in the human colon
31. Preparation of Escherichia coli ribosomal subunits active in polypeptide synthesis
32. Structural analysis of RNA using chemical and enzymatic probing monitored by primer extension
33. Antibiotic usage in animals. Impact on bacterial resistance and public health
34. Streptococcal plasmid pIP501 has a functional oriT site
35. An ATP-binding cassette transporter and two rRNA methyltransferases are involved in resistance to avilamycin in the producer organism Streptomyces viridochromogenes Tü57
36. Comparison of high-level gentamicin-resistant Enterococcus faecium isolates from different continents